![Frank W. Marcoux](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Frank W. Marcoux
Vorstandsvorsitzender bei Portage Glasgow Ltd.
Aktive Positionen von Frank W. Marcoux
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Portage Pharma Ltd.
![]() Portage Pharma Ltd. Pharmaceuticals: MajorHealth Technology Part of Portage Biotech, Inc., Portage Pharma Ltd. develops pharmaceutical products. The There is no available country named vg company was founded by Declan Doogan, Gregory H. Bailey. Bruce H. Littman has been the CEO of the company since 2013. Portage Pharma was acquired by Portage Biotech, Inc. on June 04, 2013 for $34.84 million. | Technik-/Wissenschafts-/F&E-Leiter | 04.06.2013 | - |
Opsidio LLC
![]() Opsidio LLC Pharmaceuticals: MajorHealth Technology Opsidio LLC engages in developing monoclonal antibodies to treat fibrotic and remodeling diseases. The company is headquartered in Bryn Mawr, PA. | Direktor/Vorstandsmitglied | - | - |
Portage Glasgow Ltd.
![]() Portage Glasgow Ltd. Pharmaceuticals: MajorHealth Technology Portage Glasgow Ltd. develops drugs to treat chronic conditions. The private company is based in Glasgow. The CEO of the American company is Frank W. Marcoux. | Direktor/Vorstandsmitglied | - | - |
Vorstandsvorsitzender | - | - | |
Portage Pharmaceutical Ltd.
![]() Portage Pharmaceutical Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Juvenescence Ltd., Portage Pharmaceutical Ltd. is a research and developer of biotechnology pharmaceutical drugs. The company is based in Toronto, Canada. Portage Pharmaceutical was acquired by Juvenescence Ltd. from Portage Biotech, Inc. on March 04, 2021 for $193.25 million. The CEO of the Canadian company is Frank W. Marcoux. | Vorstandsvorsitzender | - | - |
Karriereverlauf von Frank W. Marcoux
Ehemalige bekannte Positionen von Frank W. Marcoux
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
PORTAGE BIOTECH INC. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Statistik
International
Vereinigte Staaten | 3 |
Kanada | 2 |
Operativ
Chief Tech/Sci/R&D Officer | 2 |
Director/Board Member | 2 |
Chief Executive Officer | 2 |
Sektoral
Health Technology | 5 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
PORTAGE BIOTECH INC. | Health Technology |
Private Unternehmen | 4 |
---|---|
Portage Pharma Ltd.
![]() Portage Pharma Ltd. Pharmaceuticals: MajorHealth Technology Part of Portage Biotech, Inc., Portage Pharma Ltd. develops pharmaceutical products. The There is no available country named vg company was founded by Declan Doogan, Gregory H. Bailey. Bruce H. Littman has been the CEO of the company since 2013. Portage Pharma was acquired by Portage Biotech, Inc. on June 04, 2013 for $34.84 million. | Health Technology |
Opsidio LLC
![]() Opsidio LLC Pharmaceuticals: MajorHealth Technology Opsidio LLC engages in developing monoclonal antibodies to treat fibrotic and remodeling diseases. The company is headquartered in Bryn Mawr, PA. | Health Technology |
Portage Glasgow Ltd.
![]() Portage Glasgow Ltd. Pharmaceuticals: MajorHealth Technology Portage Glasgow Ltd. develops drugs to treat chronic conditions. The private company is based in Glasgow. The CEO of the American company is Frank W. Marcoux. | Health Technology |
Portage Pharmaceutical Ltd.
![]() Portage Pharmaceutical Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Juvenescence Ltd., Portage Pharmaceutical Ltd. is a research and developer of biotechnology pharmaceutical drugs. The company is based in Toronto, Canada. Portage Pharmaceutical was acquired by Juvenescence Ltd. from Portage Biotech, Inc. on March 04, 2021 for $193.25 million. The CEO of the Canadian company is Frank W. Marcoux. | Commercial Services |
- Börse
- Insiders
- Frank W. Marcoux
- Erfahrung